Appointments:

Professor
Department of Medicine
     Section of Hematology / Oncology

Committee on Cancer Biology

Education:

M.D., Yale University, 1988

B.S., University of Illinois, 1984

Contact:

Phone:  (773) 702-4150

Fax:       (773) 834-0188

E-Mail: wstadler@medicine.bsd.uchicago.edu

Address:

The University of Chicago
AMB I214, (MC 2115)
5841 South Maryland Avenue
Chicago, Illinois 60637

Related Research Interests:

 

Walter M. Stadler, M.D.


Late Phase I and Phase II Clinical Trials for Genitourinary Cancers with Special Emphasis on
Targeted Herpies and Pharmacodynamic Markers of Drug Effect

Research Summary


Dr. Stadler focuses on the treatment of patients with kidney, bladder, prostate, and testes cancer. His research interests are related to new drug development for these patients. To this end he continues to design and conduct phase I, II, and III clinical trials. He is also active in developing new blood based, pathologic, and imaging markers to assist in monitoring of therapy and predicting patient outcome.


Selected Papers

Vogelzang NJ, Stadler WM. (1998). Kidney Cancer. Lancet 352:1691-1696.

Kaufman D, Raghavan D, Carducci M, Levine EG, Murphy B, Aisner J, Kuzel T, Nicol S, Stadler W. (2000). Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. J Clin Oncol 18:1921-1927.

Stadler WM, Hayden A, von der Maase H, Roychowdhury D, Dogliotti L, Seymour L, Kaufman D, Moore M. (2002). Long term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer. Urologic Oncology 7:153-157.

Stadler WM, Huo D, George C, Yang X, Ryan CW, Karrison T, Zimmerman TM, Vogelzang NJ. (2003). Prognostic Factors for Survival to Gemcitabine Plus 5-FU Based Regimens in Metastatic Renal Cancer. J Urol 170:1141-1145.

Medved M, Karczmar G, Yang C, Dignam J, Gajewski TJ, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. (2004). Semi-quantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J. Magn Reson Imaging 20:122-128.

 

Faculty and Research

Programs

Cancer Biology


CCB

Immunology


CCB

Microbiology


CCB

Molecular Metabolism
and Nutrition


CCB

Molecular Pathogenesis and
Molecular Medicine


CCB